A Single-arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates
What is the purpose of this trial?
- 18 Years and older
- Amgen, Inc
- February 2010
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale2544018